EUVIMEDEUVIMED entdecken
Crossref

Comprehensive metabolic characterization of GBT1118 in humans using a combined approach via UHPLC-HRMS for doping control

Jing Jing, Xueqi Liang, Xi Chen, Tian Tian

Analytical and Bioanalytical Chemistry · 2026

DOI: 10.1007/s00216-026-06478-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Jing Jing und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Anti-doping Laboratory, Shanghai University of Sport, 900 Jiangwancheng Road, Shanghai, 200438, China. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Liquid Chromatography-Mass Spectrometry, Performance-Enhancing Substances. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificially enhancing muscular oxygen (O2) delivery represents a major cheating method in competitive sports. GBT1118, an emerging hemoglobin S polymerization inhibitor (HbS-PI), has demonstrated considerable performance-enhancing effect by increasing the Hb affinity for O2, raising concerns about potential abuse in athletics. However, the lack of metabolic knowledge and ethical restrictions on human subjects hinder the effective doping control of GBT1118. In this study, comprehensive metabolic profiling of GBT1118 was characterized by combining a human liver microsomes in vitro model and a multi-dimensional data mining strategy. Orbitrap-based ultra-high-performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) in data-dependent acquisition (DDA) mode was utilized to detect both phase-I and phase-II reaction products, together with in silico prediction and a home-made HbS-PI biotransformation database for in-depth metabolite screening. After duplicate exclusion, manual identification and verification with synthetic standards, extensive metabolism including 21 phase-I metabolites and 8 phase-II metabolites was discovered for GBT1118. Structure assignment revealed several key metabolic sites and diverse biotransformation pathways, including ester hydrolysis, aldehyde reduction, aldehyde oxidation, hydroxylation (monohydroxylation and dihydroxylation), glucuronidation, and the cross-combination of these pathways. Notably, the high proportion of glucuronide conjugates (> 60%) suggests the necessity of implementing enzymatic hydrolysis in routine anti-doping analyses. Furthermore, based on metabolite abundance and a comparative analysis with a recent in vivo metabolic study of an analogue, the drug prototype and two metabolites are proposed as promising urinary markers for abuse monitoring. This study provides the first comprehensive insight into the human-relevant metabolic profile of GBT1118, offering valuable guidance for doping control, which also serves as an effective tool for human metabolic research of other HbS-PIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionLiquid Chromatography-Mass SpectrometryPerformance-Enhancing SubstancesHumansChromatography, High Pressure LiquidMicrosomes, Liver

Stichwörter der Autor:innen

Doping controlGBT1118Hemoglobin S polymerization inhibitor (HbS-PI)Human liver microsomesMetabolic profile

Substanzen

Performance-Enhancing Substances

Autor:innen und Institutionen

  • Shanghai Anti-doping Laboratory, Shanghai University of Sport, 900 Jiangwancheng Road, Shanghai, 200438, China.
  • Baoshan District Center for Disease Control and Prevention (Baoshan District Health Inspection Institute), 158 Yueming Road, Shanghai, 201901, China.
  • Shanghai Anti-doping Laboratory, Shanghai University of Sport, 900 Jiangwancheng Road, Shanghai, 200438, China. tiantian@sus.edu.cn.

Förderung

  • Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai

Zitieren

APA

Jing, J., Liang, X., Chen, X., & Tian, T. (2026). Comprehensive metabolic characterization of GBT1118 in humans using a combined approach via UHPLC-HRMS for doping control. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-026-06478-2

Vancouver

Jing J, Liang X, Chen X, Tian T. Comprehensive metabolic characterization of GBT1118 in humans using a combined approach via UHPLC-HRMS for doping control. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-026-06478-2

BibTeX
@article{Jing2026,
  author = {Jing, Jing and Liang, Xueqi and Chen, Xi and Tian, Tian},
  title = {Comprehensive metabolic characterization of GBT1118 in humans using a combined approach via UHPLC-HRMS for doping control},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  doi = {10.1007/s00216-026-06478-2}
}
Kostenlos starten →